{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:15:36Z","timestamp":1754162136426,"version":"3.41.2"},"reference-count":56,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Lo-Hsu Medical Foundation, LotungPoh-Ai Hospital","award":["11303","11304"],"award-info":[{"award-number":["11303","11304"]}]},{"name":"Research and Development Program of China","award":["2023YFC2506903"],"award-info":[{"award-number":["2023YFC2506903"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Health Care Inform"],"accepted":{"date-parts":[[2025,6,21]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate the association between perioperative dexmedetomidine (DEX) use and oncological outcomes\u2014including locoregional recurrence (LRR) and distant metastasis (DM)\u2014in patients undergoing curative surgery for oral cavity squamous cell carcinoma (OCSCC).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective cohort study used data from the Taiwan Cancer Registry Database and included patients with stage I\u2013IVB OCSCC who underwent curative surgery between 2007 and 2019. Patients were categorised by DEX exposure status and matched 1:1 using propensity score matching (PSM) based on key clinical and demographic variables. Cox proportional hazards models and competing risk analyses were used to estimate the association between DEX use and oncological outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>After PSM, 8024 patients (4012 per group) were included. Multivariable Cox regression showed that perioperative DEX use was significantly associated with increased risks of LRR (adjusted HR (aHR) 1.67; 95% CI 1.55 to 1.80; p&lt;0.001) and DM (aHR 1.30; 95%\u2009CI 1.19 to 1.42; p&lt;0.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>These findings suggest a potential oncological risk associated with perioperative DEX administration. Possible mechanisms include immune modulation and enhanced metastatic potential, as reported in preclinical studies. Further investigation is needed to clarify causal pathways and identify patient subgroups most affected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Perioperative DEX use is independently associated with increased risks of LRR and DM in OCSCC patients. These results underscore the importance of cautious perioperative management and the need for prospective validation in randomised clinical trials.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjhci-2024-101344","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T17:49:47Z","timestamp":1751910587000},"page":"e101344","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of perioperative dexmedetomidine on recurrence and survival outcomes in oral cavity squamous cell carcinoma"],"prefix":"10.1136","volume":"32","author":[{"given":"Mingyang","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China"},{"name":"Institute of Electrophysiology, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peilin","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China"},{"name":"Department of Anesthesiology and Perioperative Medicine, Zhengzhou University, Henan Provincial People\u2019s Hospital, Zhengzhou, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Ming","family":"Chen","sequence":"additional","affiliation":[{"name":"Big Data Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan"},{"name":"Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan"},{"name":"Artificial Intelligence Development Cente, Fu Jen Catholic University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5637-558X","authenticated-orcid":false,"given":"Szu-Yuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Big Data Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan"},{"name":"Artificial Intelligence Development Cente, Fu Jen Catholic University, Taipei, Taiwan"},{"name":"Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan"},{"name":"Centers for Regional Anesthesia and Pain Medicine, Taipei Municipal Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan"},{"name":"Division of Radiation Oncology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China"},{"name":"Institute of Electrophysiology, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, China"},{"name":"Department of Anesthesiology and Perioperative Medicine, Zhengzhou University, Henan Provincial People\u2019s Hospital, Zhengzhou, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"2025072913302966000_32.1.e101344.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105451"},{"key":"2025072913302966000_32.1.e101344.2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jcsm.13162","article-title":"Comparison of surgical complications after curative surgery in patients with oral cavity squamous cell carcinoma and sarcopenia","volume":"14","author":"Zeng","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2025072913302966000_32.1.e101344.3","first-page":"1299","article-title":"Effect of Preexisting Sarcopenia on Acute and Late Postoperative Pneumonia Among Patients With Oral Cavity Squamous Cell Carcinoma","volume":"20","author":"Chen","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"2025072913302966000_32.1.e101344.4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.radonc.2020.08.016","article-title":"Definitive radiotherapy or surgery for early oral squamous cell carcinoma in old and very old patients: A propensity-score-matched, nationwide, population-based cohort study","volume":"151","author":"Liu","year":"2020","journal-title":"Radiother Oncol"},{"key":"2025072913302966000_32.1.e101344.5","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hed.24763","article-title":"High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer","volume":"39","author":"Chang","year":"2017","journal-title":"Head Neck"},{"key":"2025072913302966000_32.1.e101344.6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20671","article-title":"Assessment of Predictive Scoring System for 90-Day Mortality Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Completed Concurrent Chemoradiotherapy","volume":"3","author":"Lin","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025072913302966000_32.1.e101344.7","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16340"},{"key":"2025072913302966000_32.1.e101344.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2006.10.003"},{"key":"2025072913302966000_32.1.e101344.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2014.04.010"},{"key":"2025072913302966000_32.1.e101344.10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003268","article-title":"Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025072913302966000_32.1.e101344.11","first-page":"1119","article-title":"Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs (Abingdon Engl)"},{"key":"2025072913302966000_32.1.e101344.12","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.21037\/apm-21-1989","article-title":"Dexmedetomidine: a magic bullet on its way into palliative care-a narrative review and practice recommendations","volume":"11","author":"Gaertner","year":"2022","journal-title":"Ann Palliat Med"},{"key":"2025072913302966000_32.1.e101344.13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/joacp.JOACP_299_16","article-title":"Intraoperative use of dexmedetomidine is associated with decreased overall survival after lung cancer surgery","volume":"33","author":"Cata","year":"2017","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"2025072913302966000_32.1.e101344.14","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1002\/cam4.2654","article-title":"Effects of serum from breast cancer surgery patients receiving perioperative dexmedetomidine on breast cancer cell malignancy: A prospective randomized controlled trial","volume":"8","author":"Liu","year":"2019","journal-title":"Cancer Med"},{"key":"2025072913302966000_32.1.e101344.15","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s13402-024-00944-8","article-title":"Dexmedetomidine promotes colorectal cancer progression via Piwil2 signaling","volume":"47","author":"Dong","year":"2024","journal-title":"Cell Oncol (Dordr)"},{"key":"2025072913302966000_32.1.e101344.16","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.278"},{"key":"2025072913302966000_32.1.e101344.17","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-13-0079"},{"key":"2025072913302966000_32.1.e101344.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2017.11.004"},{"key":"2025072913302966000_32.1.e101344.19","doi-asserted-by":"publisher","DOI":"10.1097\/aln.0000000000002401"},{"key":"2025072913302966000_32.1.e101344.20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s12276-020-0461-6","article-title":"Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation","volume":"52","author":"Chen","year":"2020","journal-title":"Exp Mol Med"},{"key":"2025072913302966000_32.1.e101344.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2005.09.025"},{"key":"2025072913302966000_32.1.e101344.22","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0347(199701)19:1<14::AID-HED3>3.0.CO;2-Y"},{"key":"2025072913302966000_32.1.e101344.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.09.071"},{"key":"2025072913302966000_32.1.e101344.24","unstructured":"oncology NCpgi . NCCN clinical practice guidelines in oncology: esophageal and esophagogastric junction cancers [version 3.2023]. 94 N Woodhull Rd, Huntington, NY 11743 Harborside Press, LLC; 2023."},{"key":"2025072913302966000_32.1.e101344.25","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jtho.2023.12.021","article-title":"Comparative Effectiveness of Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiotherapy for Patients With Inoperable Esophageal Squamous Cell Carcinoma Undergoing Curative-Intent Concurrent Chemoradiotherapy","volume":"19","author":"Chang","year":"2024","journal-title":"J Thorac Oncol"},{"key":"2025072913302966000_32.1.e101344.26","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jtho.2023.04.005","article-title":"Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Nationwide Cohort Study","volume":"18","author":"Chen","year":"2023","journal-title":"J Thorac Oncol"},{"key":"2025072913302966000_32.1.e101344.27","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/hed.26575","article-title":"Definitive intensity-modulated radiotherapy or surgery for early oral cavity squamous cell carcinoma: Propensity-score-matched, nationwide, population-based cohort study","volume":"43","author":"Liu","year":"2021","journal-title":"Head Neck"},{"key":"2025072913302966000_32.1.e101344.28","first-page":"1481","article-title":"Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation","volume":"71","author":"Hoy","year":"2011","journal-title":"Drugs (Abingdon Engl)"},{"key":"2025072913302966000_32.1.e101344.29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1532-5415.2010.02767.x","article-title":"Competing Risk of Death: An Important Consideration in Studies of Older Adults","volume":"58","author":"Berry","year":"2010","journal-title":"J American Geriatrics Society"},{"key":"2025072913302966000_32.1.e101344.30","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwp107"},{"key":"2025072913302966000_32.1.e101344.31","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1210"},{"key":"2025072913302966000_32.1.e101344.32","doi-asserted-by":"publisher","DOI":"10.1002\/pst.433"},{"key":"2025072913302966000_32.1.e101344.33","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5705"},{"key":"2025072913302966000_32.1.e101344.34","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5984"},{"key":"2025072913302966000_32.1.e101344.35","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/sim.8071","article-title":"Two-stage residual inclusion for survival data and competing risks-An instrumental variable approach with application to SEER-Medicare linked data","volume":"38","author":"Ying","year":"2019","journal-title":"Stat Med"},{"key":"2025072913302966000_32.1.e101344.36","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7501"},{"key":"2025072913302966000_32.1.e101344.37","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90744-3"},{"key":"2025072913302966000_32.1.e101344.38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/ija.IJA_752_17","article-title":"Role of dexmedetomidine as an anaesthetic adjuvant in breast cancer surgery as a day-care procedure: A randomised controlled study","volume":"62","author":"Das","year":"2018","journal-title":"Indian J Anaesth"},{"key":"2025072913302966000_32.1.e101344.39","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00250","article-title":"Dexmedetomidine Improves Postoperative Patient-Controlled Analgesia following Radical Mastectomy","volume":"8","author":"Fan","year":"2017","journal-title":"Front Pharmacol"},{"key":"2025072913302966000_32.1.e101344.40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2015.06.062","article-title":"Alpha2-adrenergic blockade emulates the enhancing effect of chronic stress on breast cancer progression","volume":"49","author":"Lamkin","year":"2015","journal-title":"Brain Behav Immun"},{"key":"2025072913302966000_32.1.e101344.41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/CBM-130347","article-title":"The role of adrenergic signaling in breast cancer biology","volume":"13","author":"Obeid","year":"2013","journal-title":"Cancer Biomark"},{"key":"2025072913302966000_32.1.e101344.42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.2042-7158.2011.01382.x","article-title":"Dexmedetomidine protects against oxygen-glucose deprivation-induced injury through the I2 imidazoline receptor-PI3K\/AKT pathway in rat C6 glioma cells","volume":"64","author":"Zhang","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"2025072913302966000_32.1.e101344.43","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s13277-014-2829-5","article-title":"Vascular endothelial growth factor B coordinates metastasis of non-small cell lung cancer","volume":"36","author":"Liu","year":"2015","journal-title":"Tumour Biol"},{"key":"2025072913302966000_32.1.e101344.44","doi-asserted-by":"publisher","DOI":"10.1080\/08923970500240883"},{"key":"2025072913302966000_32.1.e101344.45","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1213\/ANE.0000000000007328","article-title":"Cancer Biology and the Perioperative Period: Opportunities for Disease Evolution and Challenges for Perioperative Care","volume":"140","author":"Perry","year":"2025","journal-title":"Anesth Analg"},{"key":"2025072913302966000_32.1.e101344.46","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s40140-015-0122-9","article-title":"Fundamental Principles of Cancer Biology: Does it have relevance to the perioperative period?","volume":"5","author":"Jiang","year":"2015","journal-title":"Curr Anesthesiol Rep"},{"key":"2025072913302966000_32.1.e101344.47","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-1536"},{"key":"2025072913302966000_32.1.e101344.48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14302\/issn.2372-6601.jhor-18-2396","article-title":"Perioperative Period is a Critical Gap for Minimal Residual Cancer Cells Progression and Therapy: Biological and Molecular Based Evidences","volume":"3","author":"Amin","year":"2018","journal-title":"JHOR"},{"key":"2025072913302966000_32.1.e101344.49","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2327143","article-title":"Trial watch: dexmedetomidine in cancer therapy","volume":"13","author":"Carnet Le Provost","year":"2024","journal-title":"Oncoimmunology"},{"key":"2025072913302966000_32.1.e101344.50","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-018-1727-9","article-title":"Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery","volume":"16","author":"Su","year":"2018","journal-title":"J Transl Med"},{"key":"2025072913302966000_32.1.e101344.51","first-page":"4820","article-title":"Dexmedetomidine enhances hypoxia\u2011induced cancer cell progression","volume":"18","author":"Chen","year":"2019","journal-title":"Exp Ther Med"},{"key":"2025072913302966000_32.1.e101344.52","first-page":"931","article-title":"Dexmedetomidine Promotes Angiogenesis and Vasculogenic Mimicry in Human Hepatocellular Carcinoma through \u03b1 2-AR\/HIF-1\u03b1\/VEGFA Pathway","volume":"35","author":"Fang","year":"2022","journal-title":"Biomed Environ Sci"},{"key":"2025072913302966000_32.1.e101344.53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00432","article-title":"Distinct Effects of Dexamethasone on Human Natural Killer Cell Responses Dependent on Cytokines","volume":"8","author":"Morgan","year":"2017","journal-title":"Front Immunol"},{"key":"2025072913302966000_32.1.e101344.54","first-page":"151","article-title":"NK cells mediate the anti-tumor effects of E1-deleted, type 5 adenovirus in a human tumor xenograft model","volume":"7","author":"Nielsen","year":"2000","journal-title":"Oncol Rep"},{"key":"2025072913302966000_32.1.e101344.55","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(83)90263-0"},{"key":"2025072913302966000_32.1.e101344.56","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s10787-017-0418-0","article-title":"Regulatory effects of dexamethasone on NK and T cell immunity","volume":"26","author":"Chen","year":"2018","journal-title":"Inflammopharmacology"}],"container-title":["BMJ Health &amp; Care Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjhci-2024-101344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:30:44Z","timestamp":1753821044000},"score":1,"resource":{"primary":{"URL":"https:\/\/informatics.bmj.com\/lookup\/doi\/10.1136\/bmjhci-2024-101344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,7,7]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjhci-2024-101344"],"URL":"https:\/\/doi.org\/10.1136\/bmjhci-2024-101344","relation":{},"ISSN":["2632-1009"],"issn-type":[{"type":"electronic","value":"2632-1009"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}